These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20055744)

  • 1. A dark strain in the Fusarium solani species complex isolated from primary subcutaneous sporotrichioid lesions associated with traumatic inoculation via a rose bush thorn.
    Kantarcioglu AS; Summerbell RC; Sutton DA; Yücell A; Sarikaya E; Kaner G; Iscimen A; Altas K
    Med Mycol; 2010 Feb; 48(1):103-9. PubMed ID: 20055744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping of Fusarium Isolates from Onychomycoses in Colombia: Detection of Two New Species Within the Fusarium solani Species Complex and In Vitro Antifungal Susceptibility Testing.
    Guevara-Suarez M; Cano-Lira JF; de García MC; Sopo L; De Bedout C; Cano LE; García AM; Motta A; Amézquita A; Cárdenas M; Espinel-Ingroff A; Guarro J; Restrepo S; Celis A
    Mycopathologia; 2016 Apr; 181(3-4):165-74. PubMed ID: 26943726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitypification of Fusisporium (Fusarium) solani and its assignment to a common phylogenetic species in the Fusarium solani species complex.
    Schroers HJ; Samuels GJ; Zhang N; Short DP; Juba J; Geiser DM
    Mycologia; 2016; 108(4):806-19. PubMed ID: 27055573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
    Kantarcioğlu AS; Boekhout T; De Hoog GS; Theelen B; Yücel A; Ekmekci TR; Fries BC; Ikeda R; Koslu A; Altas K
    Med Mycol; 2007 Mar; 45(2):173-81. PubMed ID: 17365654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
    Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A
    Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
    Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inordinate fondness for Fusarium: phylogenetic diversity of fusaria cultivated by ambrosia beetles in the genus Euwallacea on avocado and other plant hosts.
    Kasson MT; O'Donnell K; Rooney AP; Sink S; Ploetz RC; Ploetz JN; Konkol JL; Carrillo D; Freeman S; Mendel Z; Smith JA; Black AW; Hulcr J; Bateman C; Stefkova K; Campbell PR; Geering AD; Dann EK; Eskalen A; Mohotti K; Short DP; Aoki T; Fenstermacher KA; Davis DD; Geiser DM
    Fungal Genet Biol; 2013 Jul; 56():147-57. PubMed ID: 23608321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
    Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ
    Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatitis and systemic mycosis in lined seahorses Hippocampus erectus associated with a marine-adapted Fusarium solani species complex pathogen.
    Salter CE; O'Donnell K; Sutton DA; Marancik DP; Knowles S; Clauss TM; Berliner AL; Camus AC
    Dis Aquat Organ; 2012 Oct; 101(1):23-31. PubMed ID: 23047188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
    Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC
    Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
    Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
    Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Fusarium from a patient with fungemia after multiple organ injury.
    Kang Y; Li L; Zhu J; Zhao Y; Zhang Q
    Mycopathologia; 2013 Aug; 176(1-2):151-5. PubMed ID: 23703243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex.
    O'Donnell K; Sutton DA; Fothergill A; McCarthy D; Rinaldi MG; Brandt ME; Zhang N; Geiser DM
    J Clin Microbiol; 2008 Aug; 46(8):2477-90. PubMed ID: 18524963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility.
    Azor M; Gené J; Cano J; Manikandan P; Venkatapathy N; Guarro J
    J Clin Microbiol; 2009 May; 47(5):1463-8. PubMed ID: 19321723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE; Wiederhold NP; Klepser ME
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
    Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.